Content area
Abstract
The past three years have been interesting times for the biopharmaceutical industry. The rate of biopharmaceutical approvals has leveled off, but some milestones bode well for the future.
You might have access to more details...
Try and log in through your library or institution to see if they have access.
The past three years have been interesting times for the biopharmaceutical industry. The rate of biopharmaceutical approvals has leveled off, but some milestones bode well for the future.